The compound 1-hydrazinophthalazine appears to be be an antihypertensive drug of only moderate potency. Based on experience with 50 cases of arterial hypertension, it was found most effective in patients with unsuccessful sympathectomy, malignant hypertension, and neurogenic hypertension. It was relatively ineffective in renal hypertension and in a group of miscellaneous conditions. Chronic administration by mouth in outpatients was feasible.